Biogen (BIIB) Change in Acquisitions & Divestments (2009 - 2026)

Biogen's Change in Acquisitions & Divestments history runs 18 years deep, the most recent figure standing at $1.5 billion for Q2 2026.

• In Q2 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $1.5 billion; the TTM figure through Jun 2026 stood at $2.2 billion (up 3862.43% YoY), while the FY2025 annual figure was $23.0 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments for Q2 2026 stood at $1.5 billion, up from $625.2 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $5.7 billion in Q3 2023, with the low at -$96.7 million in Q4 2024.
• The 5-year median for Change in Acquisitions & Divestments is $543.6 million (2022), against an average of $881.0 million.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments soared 246.8% in 2023, then sank 99.85% in 2024.
• Biogen's Change in Acquisitions & Divestments stood at $566.3 million in 2022, then soared by 906.29% to $5.7 billion in 2023, then plunged by 101.7% to -$96.7 million in 2024, then soared by 65.25% to -$33.6 million in 2025, then jumped by 4609.52% to $1.5 billion in 2026.
• Business Quant data shows BIIB's Change in Acquisitions & Divestments at $1.5 billion in Q2 2026, $625.2 million in Q1 2026, and -$33.6 million in Q4 2025.